封面
市场调查报告书
商品编码
1308792

有效性测试市场:按测试类型、按用途- 俄罗斯-乌克兰衝突、高通膨的累积影响 - 2023-2030 年全球预测

Efficacy Testing Market by Test Type, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球功效检测市场预计将大幅成长,预计2023年将达到3.067亿美元,年复合成长率为6.80%,预计2030年将达到4.8676亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球功效测试市场至关重要。透过检查业务策略和产品满意度的关键指标,我们对供应商进行全面评估,使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限,并取得了不同程度的成功:前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献,可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解:

1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。

2. 市场开发:提供有关利润丰厚的新兴市场的详细资讯,并分析其在成熟市场的渗透率。

3. 市场多元化:提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势:全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题:

1. 全球功效检测市场规模及预测是多少?

2.在预测期内,COVID-19对全球功效测试市场的抑制要素和影响是什么?

3.在预测期内,全球药效测试市场需要投资哪些产品/细分市场/应用/领域?

4.全球药效检测市场的竞争策略是什么?

5. 全球药效测试市场的技术趋势和法律规范是什么?

6.全球功效检测市场主要厂商的市占率为何?

7. 哪些型态和策略措施被认为适合进入全球功效检测市场?

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 注重产品污染控制
      • 增加製药业研发活动的投资
      • 扩大抗菌功效测试在各种医疗器材中的用途
    • 抑制因素
      • 各种功效测试和试验成本高
    • 机会
      • 关于新产品安全性和稳定性的政府政策和倡议,主要是在製药和医疗领域。
      • 持续开发先进的功效测试
    • 任务
      • 功效研究的批准是一个复杂且耗时的过程
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章按测试类型分類的有效性测试市场

  • 抗菌/防腐功效测试
    • 快速测试方法
    • 常规测试方法
  • 消毒剂功效测试
    • 表面测试方法
    • 悬浮试验方法

第7章有效性测试市场:依用途

  • 消费性产品
  • 化妆品和个人护理产品
  • 医用器材
  • 药品製造

第8章美洲药效测试市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第9章亚太效度测验市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东及非洲药效检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第11章竞争形势

  • FPNV定位矩阵
  • 市占率分析:主要企业
  • 竞争情境分析:主要企业

第12章上市公司名单

第13章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-4F4C362635CB

The Global Efficacy Testing Market is forecasted to grow significantly, with a projected USD 306.70 million in 2023 at a CAGR of 6.80% and expected to reach a staggering USD 486.76 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Efficacy Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Efficacy Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Test Type, market is studied across Antimicrobial/Preservative Efficacy Testing and Disinfectant Efficacy Testing. The Antimicrobial/Preservative Efficacy Testing is further studied across Rapid Test Method and Traditional Test Method. The Disinfectant Efficacy Testing is further studied across Surface Test Method and Suspension Test Method. The Disinfectant Efficacy Testing is projected to witness significant market share during forecast period.

Based on Application, market is studied across Consumer Product, Cosmetics & Personal Care Product, Medical Device, and Pharmaceutical Manufacturing. The Consumer Product is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Efficacy Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Efficacy Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Efficacy Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Efficacy Testing Market?

4. What is the competitive strategic window for opportunities in the Global Efficacy Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Efficacy Testing Market?

6. What is the market share of the leading vendors in the Global Efficacy Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Efficacy Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Efficacy Testing Market, by Test Type, 2022 vs 2030
  • 4.3. Efficacy Testing Market, by Application, 2022 vs 2030
  • 4.4. Efficacy Testing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High focus on contamination control in products
      • 5.1.1.2. Increasing investments for the research and development activities in the pharmaceutical sector
      • 5.1.1.3. Growing applications of antimicrobial efficacy testing in various medical devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost involved in different efficacy testing and trials
    • 5.1.3. Opportunities
      • 5.1.3.1. Government policies and efforts towards new product safety and stability mainly in the pharma and medical sector
      • 5.1.3.2. Ongoing development of advanced efficacy testing
    • 5.1.4. Challenges
      • 5.1.4.1. Complex and time-consuming process for approval for efficacy testing
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Efficacy Testing Market, by Test Type

  • 6.1. Introduction
  • 6.2. Antimicrobial/Preservative Efficacy Testing
    • 6.2.1. Rapid Test Method
    • 6.2.2. Traditional Test Method
  • 6.3. Disinfectant Efficacy Testing
    • 6.3.1. Surface Test Method
    • 6.3.2. Suspension Test Method

7. Efficacy Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Consumer Product
  • 7.3. Cosmetics & Personal Care Product
  • 7.4. Medical Device
  • 7.5. Pharmaceutical Manufacturing

8. Americas Efficacy Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Efficacy Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Efficacy Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. EFFICACY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. EFFICACY TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. EFFICACY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2022 VS 2030 (%)
  • FIGURE 5. EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. EFFICACY TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. EFFICACY TESTING MARKET DYNAMICS
  • FIGURE 8. EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES EFFICACY TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. EFFICACY TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. EFFICACY TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. EFFICACY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. EFFICACY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 6. EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. EFFICACY TESTING MARKET SIZE, BY RAPID TEST METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. EFFICACY TESTING MARKET SIZE, BY TRADITIONAL TEST METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 10. EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. EFFICACY TESTING MARKET SIZE, BY SURFACE TEST METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. EFFICACY TESTING MARKET SIZE, BY SUSPENSION TEST METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. EFFICACY TESTING MARKET SIZE, BY CONSUMER PRODUCT , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. EFFICACY TESTING MARKET SIZE, BY COSMETICS & PERSONAL CARE PRODUCT , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. EFFICACY TESTING MARKET SIZE, BY MEDICAL DEVICE , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. EFFICACY TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES EFFICACY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. VIETNAM EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. DENMARK EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EGYPT EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. FINLAND EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FRANCE EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. GERMANY EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. ISRAEL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ITALY EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NIGERIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NORWAY EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. POLAND EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. QATAR EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. RUSSIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SPAIN EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SWEDEN EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWITZERLAND EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. TURKEY EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. EFFICACY TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 187. EFFICACY TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 188. EFFICACY TESTING MARKET LICENSE & PRICING